Search
+
    SEARCHED FOR:

    FY22

    Getting ready to end the 3-year exile: 5 stocks from diagnostics sector with upside potential of up to 53%

    There are some businesses, where only a black swan event leads to sharp growth in profit. Otherwise the underlying nature is such that they don't have any sudden spike in their profits. But there is constant growth. The constant growth could be because of many reasons. It may be because of the fact that penetration of that good or service is very low and over a period of time as it improves, both top and bottom line keep moving upward. It could be because of the movement of business from the unorganized sector to the organized sector. Or due the fact that the “need” of that good or service is such that spending on it cannot be postponed. In the case of diagnostic business, it is all the three, or rather four. The fact is that in 2020, a black swan took place which led to the sudden spike in FY 2021 numbers, but then back to normal growth curve. Now for three years, there has been a painful process of partial normalization of valuation and end of price wars. Has the time come for extreme long term investors to bring them back on watchlist ?

    IPO Analysis: Emcure has better-listed pharma alternatives

    Emcure Pharma, with its strong presence in gynaecology and HIV therapeutic areas, secured significant investments from anchor investors like HDFC Mutual Fund and ICICI Prudential Mutual Fund, showcasing immense market confidence in its upcoming IPO.

    CASA share likely bottomed out, to edge higher in FY25

    Witness a revolutionary shift in CASA ratios as private banks dominate with a 45% ratio in March 2023, outperforming public sector banks at 42% in the CASA deposit landscape. Stay informed on the latest developments shaping the banking sector dynamics.

    Vedanta Resources sells 2.63% stake in Indian arm, raises Rs 4,184 crore

    Vedanta Group, in a statement, said that Finsider International Company, a subsidiary of Vedanta Resources, accepted a proposal from one of its banks Tuesday evening to sell 2.6% shares holding in Vedanta Ltd to a group of reputed institutional investors.

    Anil Agarwal likely pares Vedanta stake in large block deal, shares drop 6%

    The promoters of Vedanta have reportedly sold 17.1 crore shares of the company and the transaction value is estimated to be around Rs 7,000-8,0000 crore. The official buyers and sellers of the transaction are not yet known.

    Promoter may sell 2.5% in Vedanta via block deals this week

    Agarwal has been seeking to slash the group's debt burden. London-listed Vedanta Resources reduced its net debt to $6 billion in FY24 from $9.7 billion in FY22. The company aims to cut it to $3 billion over the next three years. Vedanta Resources has long-term debt maturities of $900 million in FY25 and another $900 million in FY26.

    The Economic Times
    BACK TO TOP